Geneos Wealth Management Inc. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,536
-66.3%
4230.0%0.00%
-100.0%
Q2 2023$10,507
+65.2%
4230.0%0.00%
Q1 2023$6,362
-40.2%
423
-53.0%
0.00%
-100.0%
Q4 2022$10,6479000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 839,128$27,926,0005.24%
RA Capital Management 4,098,332$136,392,0001.89%
KLK CAPITAL MANAGEMENT LLC 45,762$1,523,0001.40%
Antara Capital LP 520,800$17,332,0001.33%
Spotlight Asset Group, Inc. 75,000$2,496,0001.24%
Nicholas Investment Partners, LP 485,838$16,169,0001.18%
MAVERICK CAPITAL LTD 3,296,451$109,706,0001.11%
SECTORAL ASSET MANAGEMENT INC 394,949$13,144,0001.09%
683 Capital Management, LLC 828,271$27,565,0001.08%
ACT CAPITAL MANAGEMENT, LLC 60,000$1,997,0001.04%
View complete list of TG THERAPEUTICS INC shareholders